Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to omicron and historical variants independent of measles seropositivity. mBio (2024), 10.1128/mbio.02928-23 Google Scholar Musunuri et al., 2024 S. Musunuri,...
To benchmark the activity of the Sarbeco RBD Mix vaccine against non-SARS-CoV-2 Sarbecoviruses, we compared it to a historical SARS-CoV-2 mRNA vaccine; we immunized K18-hACE2 mice with a prime-boost series of 0.25 μg of the BNT162b mRNA vaccine (IM-IM) or the Sarbeco RBD Mix...